Search
- Nov 4
Aleta Biotherapeutics' Paul Rennert on what he sees is working, and what isn't, at #SITC23
Paul Rennert gives an update on Aleta, and summarizes data at #SITC23 from the IO 2.0, cytokine, TGF beta, Treg, lymphoid, and CAR-T spaces.
- Jun 2
Watching cell therapy innovation at #ASCO23.
Paul Rennert of Aleta Biotherapeutics gives a rundown on the latest in cell therapies and other modalities ahead of #ASCO23.
